{"id":18,"date":"2017-01-04T15:03:07","date_gmt":"2017-01-04T20:03:07","guid":{"rendered":"https:\/\/sites.bu.edu\/evaluatingaccess-accessaccelerated\/?page_id=18"},"modified":"2017-12-05T09:55:10","modified_gmt":"2017-12-05T14:55:10","slug":"resources","status":"publish","type":"page","link":"https:\/\/sites.bu.edu\/evaluatingaccess-accessaccelerated\/resources\/","title":{"rendered":"Resources"},"content":{"rendered":"

External Organizations<\/strong><\/h4>\n
    \n
  1. International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)<\/a><\/li>\n
  2. World Bank<\/a><\/li>\n
  3. Union for International Cancer Control (UICC<\/a>)<\/li>\n<\/ol>\n

    Novartis Access Evaluation
    \n<\/strong><\/h4>\n

    Novartis Access<\/a>
    \nA social business program to increase access to medicines for non-communicable diseases (NCDs) through the direct sale of NCD medicines to governments and other public-sector customers in low and lower middle income countries.     BU is currently conducting an evaluation of Novartis Access<\/a>.<\/p>\n

    Additional Resources
    \n<\/strong><\/h4>\n

    Responding to Industry Initiatives to Increase Access to Medicines and Other Health Technologies in Countries<\/a>
    \nPublication by the WHO on Industry-led access to medicines<\/p>\n

    Sustainable Development Goals<\/a>
    \n    Target 3.4<\/a>: by 2030 reduce by one-third premature mortality from NCDs through prevention and treatment, and promote mental health and well-being.<\/p>\n

    WHO Draft NCD Framework and Targets<\/a>
    \nDraft comprehensive global monitoring framework and targets for the prevention and control of NCDs.<\/p>\n

    UNGASS Meeting on NCDs<\/a>
    \nThe United Nations General Assembly Special Session (UNGASS) is a\u00a0meeting of UN member states to assess and debate global issues such as health, gender, or in this case, the world\u2019s drug control priorities.<\/p>\n

    BUSPH Center for Global Health and Development<\/a>
    \nBoston University interdisciplinary research center housed in the Department of Global Health<\/p>\n

    Pharmaceutical Program at Boston University<\/a>
    \nGraduate certificate program in pharmaceuticals at the Boston University School of Public Health<\/p>\n

     <\/p>\n","protected":false},"excerpt":{"rendered":"

    External Organizations International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) World Bank Union for International Cancer Control (UICC) Novartis Access Evaluation Novartis Access A social business program to increase access to medicines for non-communicable diseases (NCDs) through the direct sale of NCD medicines to governments and other public-sector customers in low and lower middle income […]<\/p>\n","protected":false},"author":8926,"featured_media":0,"parent":0,"menu_order":13,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/sites.bu.edu\/evaluatingaccess-accessaccelerated\/wp-json\/wp\/v2\/pages\/18"}],"collection":[{"href":"https:\/\/sites.bu.edu\/evaluatingaccess-accessaccelerated\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.bu.edu\/evaluatingaccess-accessaccelerated\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/evaluatingaccess-accessaccelerated\/wp-json\/wp\/v2\/users\/8926"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/evaluatingaccess-accessaccelerated\/wp-json\/wp\/v2\/comments?post=18"}],"version-history":[{"count":26,"href":"https:\/\/sites.bu.edu\/evaluatingaccess-accessaccelerated\/wp-json\/wp\/v2\/pages\/18\/revisions"}],"predecessor-version":[{"id":482,"href":"https:\/\/sites.bu.edu\/evaluatingaccess-accessaccelerated\/wp-json\/wp\/v2\/pages\/18\/revisions\/482"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/evaluatingaccess-accessaccelerated\/wp-json\/wp\/v2\/media?parent=18"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}